Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
November 21, 2023
Transition care to adolescent hepatology in a tertiary center for rare adult-child liver disease
Nolwenn Laborde, Karl Barange, Chloé Girard, et al.
Pharmacotherapy
|
November 13, 2004
Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy
Haleh Bagheri, Atoussa Fouladi, Karl Barange, et al.
Arzneimittel-Forschung
|
December 4, 2010
Influence of pre-analytical conditions on plasma ribavirin concentrations
Peggy Gandia, Stêphanie Trancart, Florence Nicot, et al.
Hepatology (Baltimore, Md.)
|
November 26, 2002
"A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding
Christophe Bureau, Jean-Marie Péron, Laurent Alric, et al.
Journal of Gastroenterology and Hepatology
|
February 22, 2013
Impact of molecular adsorbent recirculating system on renal recovery in type-1 hepatorenal syndrome patients with chronic liver failure
Laurence Lavayssière, Siba Kallab, Isabelle Cardeau-Desangles, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 20, 2008
Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks
Maribel Rodriguez-Torres, Sugantha Govindarajan, Moises Diago, et al.
Clinical Transplantation
|
January 22, 2005
Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C
Nassim Kamar, Jean-Sébastien Borde, Karine Sandres-Saune, et al.
Journal of Hepatology
|
June 6, 2006
Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases
Jean-Pierre Zarski, Patrick Marcellin, Vincent Leroy, et al.
Mucosal Immunology
|
April 30, 2020
Th22 cells are efficiently recruited in the gut by CCL28 as an alternative to CCL20 but do not compensate for the loss of Th17 cells in treated HIV-1-infected individuals
Manon Nayrac, Mary Requena, Claire Loiseau, et al.
Annals of Internal Medicine
|
October 16, 2013
Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial
Faouzi Saliba, Christophe Camus, François Durand, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
November 21, 2023
Transition care to adolescent hepatology in a tertiary center for rare adult-child liver disease
Nolwenn Laborde, Karl Barange, Chloé Girard, et al.
Pharmacotherapy
|
November 13, 2004
Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy
Haleh Bagheri, Atoussa Fouladi, Karl Barange, et al.
Arzneimittel-Forschung
|
December 4, 2010
Influence of pre-analytical conditions on plasma ribavirin concentrations
Peggy Gandia, Stêphanie Trancart, Florence Nicot, et al.
Hepatology (Baltimore, Md.)
|
November 26, 2002
"A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding
Christophe Bureau, Jean-Marie Péron, Laurent Alric, et al.
Journal of Gastroenterology and Hepatology
|
February 22, 2013
Impact of molecular adsorbent recirculating system on renal recovery in type-1 hepatorenal syndrome patients with chronic liver failure
Laurence Lavayssière, Siba Kallab, Isabelle Cardeau-Desangles, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 20, 2008
Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) for 16 or 24 weeks
Maribel Rodriguez-Torres, Sugantha Govindarajan, Moises Diago, et al.
Clinical Transplantation
|
January 22, 2005
Induction therapy with either anti-CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C
Nassim Kamar, Jean-Sébastien Borde, Karine Sandres-Saune, et al.
Journal of Hepatology
|
June 6, 2006
Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases
Jean-Pierre Zarski, Patrick Marcellin, Vincent Leroy, et al.
Mucosal Immunology
|
April 30, 2020
Th22 cells are efficiently recruited in the gut by CCL28 as an alternative to CCL20 but do not compensate for the loss of Th17 cells in treated HIV-1-infected individuals
Manon Nayrac, Mary Requena, Claire Loiseau, et al.
Annals of Internal Medicine
|
October 16, 2013
Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial
Faouzi Saliba, Christophe Camus, François Durand, et al.
Page
of 4